Milena Čavić

1.2k total citations
59 papers, 682 citations indexed

About

Milena Čavić is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Milena Čavić has authored 59 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Milena Čavić's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Milena Čavić is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Milena Čavić collaborates with scholars based in Serbia, Spain and Netherlands. Milena Čavić's co-authors include Ana Krivokuća, Estefanía Moreno, Enric I. Canela, Radmila Janković, Vicent Casadó, Marija Gavrović‐Jankulović, Emina Mališić, Tatjana Srdić‐Rajić, Siniša Radulović and Milica Grozdanović and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Milena Čavić

55 papers receiving 672 citations

Peers

Milena Čavić

ONCOL

PRM

PHARM

C.-W. Chi Taiwan

Guowang Yang China

Yong‐Seok Song United States

Agnieszka Gomułkiewicz Poland

Xiaodong Peng China

Xuemei Fan China

Lei Feng China

Francesco Mariani Italy

Amanda J. Unsworth United Kingdom

Norio Iizuka Japan

C.-W. Chi Taiwan

Milena Čavić

83 ×0.4

ONCOL

240 ×1.5

69 ×0.5

PRM

50 ×0.4

PHARM

108 ×1.1

Citations per year, relative to Milena Čavić Milena Čavić (= 1×) peers C.-W. Chi

Countries citing papers authored by Milena Čavić

Since Specialization

Citations

This map shows the geographic impact of Milena Čavić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milena Čavić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milena Čavić more than expected).

Fields of papers citing papers by Milena Čavić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milena Čavić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milena Čavić. The network helps show where Milena Čavić may publish in the future.

Co-authorship network of co-authors of Milena Čavić

This figure shows the co-authorship network connecting the top 25 collaborators of Milena Čavić. A scholar is included among the top collaborators of Milena Čavić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milena Čavić. Milena Čavić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stojanović-Rundić, Suzana, Dušica Gavrilović, Radmila Janković, et al.. (2025). Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT. Medicina. 61(3). 483–483.

Čavić, Milena, Ana Damjanović, Ana Krivokuća, et al.. (2024). Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia. Biomedicines. 12(10). 2278–2278. 1 indexed citations

Jevric, M., Olivera Mitrović Ajtić, Miljana Tanić, et al.. (2023). Nischarin expression may have differing roles in male and female melanoma patients. Journal of Molecular Medicine. 101(8). 1001–1014. 1 indexed citations

Tanić, Miljana, et al.. (2023). EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia. Translational Oncology. 37. 101772–101772. 4 indexed citations

Stojanović-Rundić, Suzana, Dušica Gavrilović, Radmila Janković, et al.. (2023). Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Frontiers in Genetics. 14. 6 indexed citations

Samiotaki, Martina, Vasiliki Lygirou, Suzana Stojanović-Rundić, et al.. (2023). Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. International Journal of Molecular Sciences. 24(20). 15412–15412. 9 indexed citations

Popović, Marina, Suzana Stojanović-Rundić, Miloš Nikolić, et al.. (2022). Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients. BioMed Research International. 2022(1). 7943609–7943609. 2 indexed citations

Čavić, Milena, et al.. (2022). Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-Response. 20(2). 1495861618–1495861618. 2 indexed citations

Vujović, Katarina Savić, et al.. (2021). Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity. Expert Review of Anticancer Therapy. 21(6). 673–679. 8 indexed citations

10.

Radosavljević, Davorin, Dušica Gavrilović, Tamara Čaćev, et al.. (2021). Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients. Medicina. 57(10). 1108–1108. 16 indexed citations

11.

Stojanović-Rundić, Suzana, Milena Čavić, Dušica Gavrilović, et al.. (2021). The role of haematological parameters in predicting the response to radical chemoradiotherapy in patients with anal squamous cell cancer. Radiology and Oncology. 55(4). 449–458. 5 indexed citations

12.

Čavić, Milena, et al.. (2020). Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals. Expert Review of Molecular Diagnostics. 21(1). 101–107. 14 indexed citations

13.

Čavić, Milena, Ana Krivokuća, Miljana Tanić, et al.. (2020). EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(6). 2635–2642. 6 indexed citations

14.

Grahovac, Jelena, et al.. (2019). Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics. Cancer Biology and Medicine. 16(2). 247–247. 22 indexed citations

15.

Mališić, Emina, et al.. (2018). Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination?. PubMed. 19(4). 973–9. 4 indexed citations

16.

Tanić, Miljana, Ana Krivokuća, Milena Čavić, et al.. (2018). Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer. Radiation Oncology. 13(1). 193–193. 16 indexed citations

17.

Čavić, Milena, Ana Krivokuća, Katarina Jovanović, et al.. (2017). Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.. PubMed. 21(5). 1287–1295. 12 indexed citations

18.

Čavić, Milena, Milica Grozdanović, Aleksandar Bajić, et al.. (2014). The effect of kiwifruit (Actinidia deliciosa) cysteine protease actinidin on the occludin tight junction network in T84 intestinal epithelial cells. Food and Chemical Toxicology. 72. 61–68. 17 indexed citations

19.

Mališić, Emina, et al.. (2012). The Usability of Allele-Specific PCR and Reverse-Hybridization Assays for KRAS Genotyping in Serbian Colorectal Cancer Patients. Digestive Diseases and Sciences. 58(4). 998–1003. 9 indexed citations

20.

Rakar, S, et al.. (1990). Prognostic factors in ovarian cancer.. PubMed. 11(3). 171–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact